Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Blue Haven Initiative is an active, US-based family office and impact investment organization founded in 2012 by Liesel Pritzker Simmons and Ian Simmons. It manages a diversified global portfolio across asset classes—including public equities, fixed income, private equity, direct investments, and grants—with the goal of achieving both competitive financial returns and meaningful social/environmental impact. The firm invests globally with particular focus on Sub-Saharan Africa in sectors such as climate/clean energy, education technology, financial services/inclusion, affordable real estate, and healthcare. While it does invest in healthcare companies as part of its broader impact strategy, it is not itself a life science/biotech/pharma/healthcare company or platform.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Blue Haven Initiative.